Svenningsen Sarah, Guo Fumin, Kirby Miranda, Choy Stephen, Wheatley Andrew, McCormack David G, Parraga Grace
Imaging Research Laboratories, Robarts Research Institute, Western University, 1151 Richmond St North, London, Ontario, Canada N6A 5B7; Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada.
Imaging Research Laboratories, Robarts Research Institute, Western University, 1151 Richmond St North, London, Ontario, Canada N6A 5B7; Graduate Program in Biomedical Engineering, The University of Western Ontario, London, Ontario, Canada.
Acad Radiol. 2014 Nov;21(11):1402-10. doi: 10.1016/j.acra.2014.08.002.
Hyperpolarized (3)He magnetic resonance imaging (MRI) previously revealed the temporal and spatial heterogeneity of ventilation defects in asthmatics, but these findings have not been used in treatment studies or to guide personalized therapy. Our objective was to exploit the temporal and spatial information inherent to (3)He MRI and develop image processing methods to generate pulmonary ventilation temporal-spatial maps that could be used to measure, optimize, and guide asthma therapy.
In this proof-of-concept study, seven asthmatics provided written informed consent to an approved protocol and underwent spirometry and (3)He MRI on three occasions, each 5 ± 2 days apart. A registration and segmentation pipeline was developed to generate three-dimensional, temporal-spatial, pulmonary function maps. Briefly, (3)He ventilation images were segmented to generate ventilation masks that were coregistered and voxels classified according to their temporal behavior. This enabled the regional mapping of temporally persistent and intermittent ventilation defects that were normalized to the (1)H MRI thoracic cavity volume to generate persistent ventilation defect percent (VDPP) and intermittent ventilation defect percent (VDPI).
(3)He temporal-spatial pulmonary function maps identified temporally persistent and intermittent ventilation defects. VDP(I) was significantly greater in the posterior (P = .04) and inferior (P = .04) lung as compared to the anterior and superior lung. Persistent and intermittent ventilation defect percent were strongly correlated with forced expiratory volume in one second/forced vital capacity (VDP(P): r = -0.87, P = .01; VDP(I): r = -0.96, P = .0008).
Temporal-spatial pulmonary maps generated from (3)He MRI can be used to quantify temporally persistent and intermittent ventilation defects as asthma intermediate end points and targets for therapy.
超极化(3)氦磁共振成像(MRI)先前已揭示哮喘患者通气缺陷的时空异质性,但这些发现尚未用于治疗研究或指导个性化治疗。我们的目标是利用(3)氦MRI固有的时空信息,并开发图像处理方法以生成可用于测量、优化和指导哮喘治疗的肺通气时空图。
在这项概念验证研究中,七名哮喘患者书面知情同意一项批准的方案,并在三个不同时间接受肺活量测定和(3)氦MRI检查,每次间隔5±2天。开发了一种配准和分割流程以生成三维时空肺功能图。简要地说,对(3)氦通气图像进行分割以生成通气掩码,将其进行配准,并根据体素的时间行为对其进行分类。这使得能够对持续和间歇性通气缺陷进行区域映射,将其归一化到(1)氢MRI胸腔体积以生成持续通气缺陷百分比(VDPP)和间歇性通气缺陷百分比(VDPI)。
(3)氦时空肺功能图识别出了持续和间歇性通气缺陷。与肺前部和上部相比,肺后部(P = 0.04)和下部(P = 0.04)的VDP(I)明显更大。持续和间歇性通气缺陷百分比与一秒用力呼气量/用力肺活量密切相关(VDP(P):r = -0.87,P = 0.01;VDP(I):r = -0.96,P = 0.0008)。
由(3)氦MRI生成的时空肺图可用于量化作为哮喘中间终点和治疗靶点的持续和间歇性通气缺陷。